Serotonin 2A receptors and cannabinoids
| Autor: | Rebeca Diez-Alarcia, Inés Ibarra-Lecue, Leyre Urigüen |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
business.industry
Context (language use) medicine.disease Endocannabinoid system 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Mood disorders chemistry Schizophrenia Medicine Serotonin business Neurotransmitter Receptor Neuroscience 030217 neurology & neurosurgery 5-HT receptor |
| Zdroj: | Progress in Brain Research ISBN: 9780128245675 |
| DOI: | 10.1016/bs.pbr.2021.01.004 |
| Popis: | Accumulating evidence has proven that both exogenous cannabinoids as well as imbalances in the endocannabinoid system are involved in the onset and development of mental disorders such as anxiety, depression, or schizophrenia. Extensive recent research in this topic has mainly focused on the molecular mechanisms by which cannabinoid agonists may contribute to the pathophysiology of these disorders. Initially, serotonin neurotransmitter garnered most attention due to its relationship to mood disorders and mental diseases, with little attention to specific receptors. To date, the focus has redirected toward the understanding of different serotonin receptors, through a demonstration of its versatile pharmacology and synergy with different modulators. Serotonin 2A receptors are a good example of this phenomenon, and the complex signaling that they trigger appears of high relevance in the context of mental disorders, especially in schizophrenia. This chapter will analyze most relevant attributes of serotonin 2A receptors and the endocannabinoid system, and will highlight the evidence toward the functional bidirectional interaction between these elements in the brain as well as the impact of the endocannabinoid system dysregulation on serotonin 2A receptors functionality. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|